EVIDENCE. COMPARISONS. CLEAR NEXT STEPS.FOR US CLINIC TEAMS PROCUREMENT RESEARCH
Direct questions

25. What integration and HIPAA questions should clinics ask a pharmacy partner?

Dose Diligence research deskSection 01 · Page 25 of 34Last updated 17 Nov 2026

Require visibility into the order lifecycle and classify each data relationship correctly. A pharmacy receiving information for treatment is not automatically a business associate simply because it receives patient information. HHS expressly distinguishes treatment disclosures from business-associate arrangements, while recognizing that another service relationship can create different obligations. (hhs.gov)

Proposed integration checklist:

  • Accepted, rejected, clarification-needed, payment-pending, shipped, delivered and cancelled statuses.
  • Reliable patient/order matching and duplicate prevention.
  • Human-readable failure reasons.
  • Audit logs, access controls and incident escalation.
  • Subcontractor disclosure and role mapping.
  • Exportable records and transition support.
  • Restrictions on secondary use, marketing and model training appropriate to the arrangement.

Where a business-associate agreement is required, HHS’s sample provisions address permitted uses, safeguards, subcontractors, reporting and termination-related handling of information. (hhs.gov)

Test the workflow with approved synthetic cases before a controlled patient pilot. Keep patient-identifiable data out of public procurement calculators and research uploads.

Sources cited on this page

  1. hhs.gov · Source 1 ↗https://www.hhs.gov/hipaa/for-professionals/faq/do-i-need-a-business-associate-contract-to-disclose-information-to-a-provider/index.html?utm_source=openai
  2. hhs.gov · Source 2 ↗https://www.hhs.gov/hipaa/for-professionals/covered-entities/sample-business-associate-agreement-provisions/index.html?utm_source=openai
Section sources →